Position in MDXH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,614
-$1,923 QoQ
Shares Held
702
-29.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 51 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $685,456,200 across 23 Diagnostics & Research names. MDXH ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,090,030 | $217,995,098 | |
| 2 | GH |
Guardant Health, Inc.
|
1,887,584 | $174,356,133 | |
| 3 | ILMN |
Illumina, Inc.
|
816,943 | $100,696,392 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
156,675 | $88,034,115 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
53,199 | $26,148,903 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
129,340 | $22,311,149 | |
| 7 | RVTY |
Revvity, Inc.
|
182,162 | $15,959,211 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
29,262 | $14,051,318 |
All Filings in MDXH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,614 | 702 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,537 | 991 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,787 | 2,750 | Shares | Defined | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||